On October 22nd the FDA announced the approval of a long-awaited antiviral treatment for COVID-19. They based this decision on three separately randomized clinical trials. For more information click on the following link:
by TLM
On October 22nd the FDA announced the approval of a long-awaited antiviral treatment for COVID-19. They based this decision on three separately randomized clinical trials. For more information click on the following link: